| For: | Krishnan A, Lucas K, Maas L, Woreta TA. Differentiating fenbendazole-induced liver injury from immunotherapy hepatitis - the importance of structured causality assessment: A case report. World J Clin Cases 2026; 14(2): 116700 [PMID: 41608149 DOI: 10.12998/wjcc.v14.i2.116700] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v14/i2/116700.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
William Supple. Letter to the Editor: Fenbendazole liver enzyme elevation in checkpoint inhibitor-treated patients as benzimidazole potentiated immunogenic tumor cell death. World Journal of Clinical Cases 2026; 14(25): 124046 doi: 10.12998/wjcc.124046
|